Terms: = Breast cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
29 results:
1. PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
Shahbaz S; Esmaeili M; Fathian Nasab MH; Imani Z; Bafkary R; Amini M; Atyabi F; Dinarvand R
Int J Pharm; 2024 Apr; 655():124024. PubMed ID: 38537920
[TBL] [Abstract] [Full Text] [Related]
2. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment.
Wang Y; Cheng W; Zhu J; He L; Ren W; Bao D; Piao JG
Biomed Pharmacother; 2024 Jan; 170():116084. PubMed ID: 38157645
[TBL] [Abstract] [Full Text] [Related]
3. Near-Infrared-Enpowered Nanomotor-Mediated Targeted Chemotherapy and Mitochondrial Phototherapy to Boost Systematic Antitumor Immunity.
Zhang X; He Q; Sun J; Gong H; Cao Y; Duan L; Yi S; Ying B; Xiao B
Adv Healthc Mater; 2022 Jul; 11(14):e2200255. PubMed ID: 35536883
[TBL] [Abstract] [Full Text] [Related]
4. Enhancement of anti-neoplastic effects of cuminaldehyde against breast cancer via mesoporous silica nanoparticle based targeted drug delivery system.
Ghosh S; Kundu M; Dutta S; Mahalanobish S; Ghosh N; Das J; Sil PC
Life Sci; 2022 Jun; 298():120525. PubMed ID: 35378139
[TBL] [Abstract] [Full Text] [Related]
5. Mesoporous Silica Nanoparticle-Based Combination of Niclosamide and Doxorubicin: Effect of treatment Regimens on breast cancer Subtypes.
Lohiya G; Katti DS
ACS Appl Bio Mater; 2021 Nov; 4(11):7811-7824. PubMed ID: 35006763
[TBL] [Abstract] [Full Text] [Related]
6. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
7. Effective Triple-Negative breast cancer Targeted treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles.
Huang J; Lai W; Wang Q; Tang Q; Hu C; Zhou M; Wang F; Xie D; Zhang Q; Liu W; Zhang Z; Zhang R
Int J Nanomedicine; 2021; 16():7497-7515. PubMed ID: 34803378
[TBL] [Abstract] [Full Text] [Related]
8. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic breast cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract] [Full Text] [Related]
9. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis.
Dong K; Zhao ZZ; Kang J; Lin LR; Chen WT; Liu JX; Wu XL; Lu TL
Int J Nanomedicine; 2020; 15():10285-10304. PubMed ID: 33376322
[TBL] [Abstract] [Full Text] [Related]
10. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment.
Shakeran Z; Keyhanfar M; Varshosaz J; Sutherland DS
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111526. PubMed ID: 33255079
[TBL] [Abstract] [Full Text] [Related]
11. Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer.
Meng F; Su Y; Xu B
Mol Oncol; 2020 Nov; 14(11):2701-2712. PubMed ID: 32941674
[TBL] [Abstract] [Full Text] [Related]
12. A Review on Recent Technologies and Patents on Silica Nanoparticles for cancer treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract] [Full Text] [Related]
13. Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy.
Bhavsar DB; Patel V; Sawant KK
Eur J Pharm Sci; 2020 Sep; 152():105428. PubMed ID: 32553643
[TBL] [Abstract] [Full Text] [Related]
14. Core-Shell-Satellite Nanomaces as Remotely Controlled Self-Fueling Fenton Reagents for Imaging-Guided Triple-Negative breast cancer-Specific Therapy.
Du Y; Yang C; Li F; Liao H; Chen Z; Lin P; Wang N; Zhou Y; Lee JY; Ding Q; Ling D
Small; 2020 Aug; 16(31):e2002537. PubMed ID: 32519453
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative breast cancer.
Xu P; Yao J; Li Z; Wang M; Zhou L; Zhong G; Zheng Y; Li N; Zhai Z; Yang S; Wu Y; Zhang D; Dai Z
Int J Nanomedicine; 2020; 15():2659-2668. PubMed ID: 32368047
[TBL] [Abstract] [Full Text] [Related]
16. Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy.
Ahir M; Upadhyay P; Ghosh A; Sarker S; Bhattacharya S; Gupta P; Ghosh S; Chattopadhyay S; Adhikary A
Biomater Sci; 2020 May; 8(10):2939-2954. PubMed ID: 32319481
[TBL] [Abstract] [Full Text] [Related]
17. Interfering msn-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
Qin Y; Chen W; Jiang G; Zhou L; Yang X; Li H; He X; Wang HL; Zhou YB; Huang S; Liu S
Sci Adv; 2020 Feb; 6(8):eaaw9960. PubMed ID: 32128390
[TBL] [Abstract] [Full Text] [Related]
18. A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer.
Li T; Geng Y; Zhang H; Wang J; Feng Y; Chen Z; Xie X; Qin X; Li S; Wu C; Liu Y; Yang H
Expert Opin Drug Deliv; 2020 May; 17(5):725-733. PubMed ID: 32098527
[No Abstract] [Full Text] [Related]
19. Rod-shape msn@MoS
Yang L; Wang J; Yang S; Lu Q; Li P; Li N
Theranostics; 2019; 9(14):3992-4005. PubMed ID: 31281527
[TBL] [Abstract] [Full Text] [Related]
20. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy.
Li H; Yan W; Suo X; Peng H; Yang X; Li Z; Zhang J; Liu D
Biomaterials; 2019 Apr; 200():1-14. PubMed ID: 30743049
[TBL] [Abstract] [Full Text] [Related]
[Next]
